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ABSTRACT
Selenocysteine is incorporated into at least 25
human proteins by a complex mechanism that is a
unique modification of canonical translation elonga-
tion. Selenocysteine incorporation requires the con-
certed action of a kink-turn structural RNA (SECIS)
element in the 30 untranslated region of each seleno-
protein mRNA, a selenocysteine-specific translation
elongation factor (eEFSec) and a SECIS binding
protein (SBP2). Here, we analyze the molecular con-
text in which SBP2 functions. Contrary to previous
findings, a combination of gel filtration chromato-
graphy and co-purification studies demonstrates
that SBP2 does not self-associate. However, SBP2
is found to be quantitatively associated with
ribosomes. Interestingly, a wild-type but not mutant
SECIS element is able to effectively compete with
the SBP2 ribosome interaction, indicating that SBP2
cannot simultaneously interact with the ribosome
and the SECIS element. This data also supports the
hypothesis that SBP2 interacts with one or more
kink turns on 28S rRNA. Based on these results,
we propose a revised model for selenocysteine
incorporation where SBP2 remains ribosome
bound except during selenocysteine delivery to the
ribosomal A-site.
INTRODUCTION
Selenocysteine (Sec), the twenty-ﬁrst amino acid, is incorpor-
ated into at least 25 human proteins at speciﬁc UGA codons
that are decoded by the Sec-tRNA
[Ser]Sec (1,2). This tRNA is
not sufﬁcient for nonsense suppression because at least two
protein factors and one additional cis-sequence are required
for Sec incorporation. The cis-sequence is termed a Sec
insertion sequence (SECIS) element that is found in all euka-
ryotic selenoprotein mRNA 30 untranslated regions, and was
originally thought to be the sole RNA element required for Sec
incorporation. This concept has been recently challenged,
however, by the discovery of a stem–loop sequence in the
coding region of selenoprotein N that is able to support
UGA readthrough in the absence of a SECIS element, albeit
for both UGA and UAG codons (3). Mammalian Sec incorp-
oration also requires the function of a Sec-speciﬁc translation
elongation factor (eEFSec/mSelB) that speciﬁcally and
exclusively binds to the Sec-tRNA
[Ser]Sec (4,5). In addition,
two speciﬁc binding partners have been identiﬁed for the
SECIS element: SECIS binding protein 2 (SBP2) and ribo-
somal protein L30 (rpL30). SBP2 is required for Sec incorp-
oration (6), while L30 has thus far been shown to enhance
Sec incorporation in transfected cells (7).
SBP2 from the rat (Rattus norvegicus) is a 94 kDa protein
with orthologues found in species ranging from Plasmodium
falciparum to mammals. Structure–function analysis of SBP2
has shown that it is comprised of three distinct domains: an
N-terminal domain for which a function has not yet been
identiﬁed, a central ‘functional domain’ that is required for
Sec incorporation but not SECIS element binding, and a
C-terminal SECIS element binding domain (8). The latter
two domains comprising the C-terminal 447 amino acids
are sufﬁcient for all three known biological activities of
SBP2: Sec incorporation, SECIS element binding and ribo-
some binding (8,9). The SBP2 SECIS element binding domain
has at its core an L7Ae RNA binding motif that is known to be
required for interacting with RNA elements known as kink
turns for several ribosomal proteins including rpL30 (10,11),
although this core motif is not sufﬁcient for SECIS element
binding (8). The L7Ae RNA binding motif is used by rpL30
for both mRNA and 28S rRNA interactions (12), thus provid-
ing the best explanation for the competition between SBP2
and L30 for SECIS element binding (7). SBP2 also binds to
ribosomes and 28S rRNA (8), and it has been proposed that
SBP2 makes ribosome contacts at one or more kink-turn
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doi:10.1093/nar/gki826motifs, but the speciﬁc ribosome binding site has not been
identiﬁed. Several reports have also suggested that SBP2 may
exist as a homomultimer based on glycerol gradient sedi-
mentation and the appearance of higher molecular weight
complexes during electrophoretic mobility shift assays
(7,8,13,14). These results led to a model where SBP2 could
simultaneously interact with the ribosome and a SECIS
element by having two RNA binding motifs available, one
for SECIS element binding and the other for 28S kink-turn
binding (15).
In this report, we characterized the aggregate molecular
weight of both full-length (FLSBP2) and C-terminal SBP2
(CTSBP2) with a variety of N-terminal tags. These studies
were carried out in the context of pull-down and ribosome
binding experiments, which compel us to signiﬁcantly alter
our model for Sec incorporation such that SBP2 cannot
simultaneously interact with the ribosome and the SECIS
element.
MATERIALS AND METHODS
Expression and purification of recombinant proteins
Thenucleotidesequencecorresponding tofull-lengthratSBP2
as well as the fully functional C-terminal half of SBP2 (amino
acids 399–846) were ampliﬁed by PCR and subcloned into
pTrcHis by TOPO-TA cloning according to the manufac-
turer’s protocol (Invitrogen) to generate Xpress/His (XH)
tagged constructs (XH-FLSBP2 and XH-CTSBP2), which
were subsequently transformed into E.coli strain BL21
(Promega). The transformed bacteria were grown in LB
medium to a density of  1.0 OD600, and then induced with
isopropyl-b-D-thiogalactoside (0.24 mg/ml; Fisher Biotech)
for 1.5 h at 30 C. The cells were pelleted, resuspended in
Buffer XH (50 mM Sodium Phosphate, pH 8.0, 1 M NaCl,
1% Tween-20, 50 mM imidazole) with protease inhibitors
(Complete, Roche) and lysed by freeze–thaw followed by
sonication for 10 s/ml. The sonicate was then centrifuged at
15000 g for 15 min at 4 C. The supernatant was applied
directly to a 1 ml HiTrap Chelating HP afﬁnity column (GE
Healthcare) charged with 10 mg/ml nickel sulfate hexahydrate
(Sigma), and tagged protein was eluted in Buffer XH with a
linear 50–500 mM imidazole gradient. Strep-tagged CTSBP2
(ST-CTSBP2) was puriﬁed as previously described (9).
Untagged CTSBP2 was created by deleting the Xpress/His
tags from the XH-CTSBP2/pTrcHis construct by mutagenic
PCR. A primer that loops out the Xpress/His tag sequence
was used to amplify the entire pTrcHis plasmid using Pfu
Turbo (Stratagene). After inducing protein expression as for
XH-CTSBP2, the cells were pelleted, resuspended in
phosphate-buffered saline (PBS) containing protease inhibit-
ors (Complete, Roche) and 2 mM DTT and lysed by freeze–
thawfollowed by sonication for10 s/ml.Thesonicatewasthen
centrifuged at 15000 g for 15 min at 4 C. Expression was
veriﬁed via western blot (see below) and total protein concen-
tration was determined by the Bradford (Bio-Rad) assay.
GST-tagged CTSBP2 (GST-CTSBP2) was created using
the same method as described for XH-CTSBP2 except the
PCR product was TOPO-TA cloned into pDEST15 (Invitro-
gen) bearing an in-frame N-terminal GST tag. The resulting
plasmid was transformed into E.coli strain BL21 (Promega).
For the co-expression of GST-CTSBP2 and XH-CTSBP2,
we created XH-CTSBP2 in pCRII-TOPO (Invitrogen) by
amplifying XH-CTSBP2 out of pTrcHis including the Trc
promoter region. This fragment was TOPO-TA cloned into
pCRII-TOPO, which lacks a bacterial promoter and contains
both ampicillin (Amp) and kanamycin (Kan) resistance genes.
The ampicillin resistance gene was deleted by digesting the
plasmid with Xmn I and Ahd I, polishing overhangs with
T4 DNA polymerase (Invitrogen) and re-ligating the plasmid
with blunt-end ligation using T4 DNA ligase as per the
manufacturer’s protocol (Invitrogen). Ligated plasmids were
transformed into DH5a by electroporation. Kan-resistant
colonies were screened for the loss of Amp resistance by
streaking individual colonies on Amp-containing plates. Plas-
mid DNA was isolated from Kan-resistant/Amp-sensitive
colonies, and transformed into BL21. The cells were grown
in LB medium containing 100 mg/ml Amp and 50 mg/ml Kan
to a density of  1.0 OD600 and then induced with L-(+)-
arabinose (0.2%; Sigma) and isopropyl-b-D-thiogalactoside
(0.24 mg/ml; Fisher Biotech) for 1.5 h at 30 C. The cells
were pelleted, resuspended in PBS with protease inhibitors
and lysed by freeze–thaw followed by sonication for
10 s/ml. The sonicate was then centrifuged at 15000 g for
15 min at 4 C. The supernatant was applied directly to a 1 ml
GSTrap FF afﬁnity column (GE Healthcare) equilibrated in
PBS, pH 7.3 and tagged protein was eluted in 50 mM Tris–
HCl, pH 8.0 containing 10 mM reduced glutathione (Sigma):
20 ml of each fraction was resolved by 12% SDS–PAGE,
transferred to nitrocellulose and probed with a 1:10000
dilution of anti Xpress-tag antibody (Invitrogen).
Gel filtration chromatography
Two gel ﬁltration chromatography columns were run using a
Beckman System Gold HPLC system (126 pumps and 168
diode array detector).A 10 · 300 mm Superdex 200 HR 10/30
(GE Healthcare) column was run at 0.4 ml/min to analyze
proteins in the 10–600 kDa range to yield 0.4 ml fractions.
A1 0· 500 mm column containing Sephacryl S-500 High
Resolution resin (GE Healthcare) was run at 0.5 ml/min to
analyze proteins in the 40–2000 kDa range to yield 0.5 ml
fractions. Prior to the injection of sample, the columns were
equilibratedwithaminimumof2columnvolumesofPBSplus
2 mM DTT (PBSD). Puriﬁed recombinant SBP2 proteins were
exchanged to PBSD by desalting on a 16 · 100 mm column
at 2 ml/min. For all molecular weight determinations, 75 mg
of puriﬁed protein was used. SBP2 content in each fraction
was determined either by SDS–PAGE or Sec incorporation
activityusingluciferase constructsaspreviouslydescribed(9).
Sizing of SBP2 was performed by comparison with standards
run under conditions identical to those for each type of
SBP2 chromatography: thyroglobulin (669 kDa), apoferritin
(443 kDa), b-Amylase (200 kDa), alcohol dehydrogenase
(150 kDa), bovine serum albumin (66 kDa), carbonic anhyd-
rase (29 kDa) and cytochrome C (12.4 kDa).
For the mixtures of SBP2 and rat testis extract, 0.4 mgo f
recombinant puriﬁed SBP2 was mixed with 15 mg rat testis
extract made ribosome-free by centrifugation at 300000 g for
1 h in a Sorvall S80-AT3. Depletion of ribosomes was con-
ﬁrmed by isolating total RNA from a portion of the extract
prior to and after centrifugation and resolving the RNA on a
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ethidium bromide staining.
For the resolution of native SBP2 complexes, a rat
hepatoma cell line (McArdle 7777) stably expressing
V5/His-tagged FLSBP2 (HV-FLSBP2) (see below) was
grown to  80% conﬂuence in 78 cm
2 plates, cells were rinsed
with PBS then lysed in PBSD by scraping followed by dounce
homogenization (10 strokes with a high clearance pestle).
Crude extracts were centrifuged for 15 min at 14000 g in an
Eppendorf 5810 R centrifuge. The supernatant was removed
and 500 ml aliquots were injected onto the Sephacryl S-500
column. Protein from each fraction was precipitated by adding
trichloroacetic acid and Tween-20 to a ﬁnal concentration
of 8% and 0.1%, respectively. Protein pellets were recovered
by centrifugation and washed in 60 ml 100% ethanol then
resuspended in 40 ml SDS–PAGE sample buffer of which
20 ml was analyzed by SDS–PAGE, transferred to nitrocellu-
lose and probed with a 1:10000 dilution of anti-V5 antibody
(Invitrogen).
Stable cell lines
V5/His-tagged FLSBP2 was subcloned into the tetracycline-
inducible plasmid, pCDNA4-TO-E (Invitrogen) by recomb-
ination from a pUni/V5-His-TOPO plasmid containing a
FLSBP2 insert. The resulting plasmid was transfected into
McArdle 7777 cells stably expressing the tetracycline repres-
sor from pCDNA6/TR using Lipofectamine (Invitrogen).
Clones were selected in 500 mg/ml Zeocin and 2 mg/ml blasti-
cidin. Pools of clones were grown to 80% conﬂuence and
analyzed as described above.
Sec incorporation assays
Recombinant SBP2 was added to a rabbit reticulocyte lysate
(Promega) Sec incorporation assay as indicated in the ﬁgure
legends. Total reaction volume was 6 ml, which included 25 ng
of luciferase reporter construct bearing a Sec (UGA) codon at
position 258 as described (9). The reactions were incubated
for 1 h at 30 C then diluted with 50 ml of PBS. Luminescence
was detected in a Dynex MLX plate luminometer using 50 ml
luciferase assay substrate (Promega).
Densitometry
Densitometry was used for three quantitative measures: (i) To
quantify relative SBP2 levels on Coomassie-stained gels con-
taining gel ﬁltration fractions. (ii) To quantify absolute SBP2
amounts based on an ovalbumin standard. (iii) To quantify
signals from western blot analysis captured on X-ray ﬁlm.
Bands of interest were quantiﬁed using ImageJ software
(Wayne Rasband, National Institutes of Health).
Western blot analysis
Western blot analysis was performed on fractions containing
lower levels of SBP2 as indicated in the ﬁgure legends.
SDS–PAGE gels were blotted to nitrocellulose membrane
(GE Healthcare), rinsed in Tris-buffered saline plus 0.1%
Tween-20 (TBST), blocked for 1 h in TBST plus 5% non-
fat dried milk then probed using the primary antibodies
indicated overnight at 4 C. Antigens were visualized using
the SuperSignal West Femto kit (Pierce) according to the
manufacturer’s protocol.
Afﬁnity-puriﬁedanti-SBP2 antibody wasmadebyresolving
5 mg XH-CTSBP2 by SDS–PAGE followed by transfer to
nitrocellulose. The protein containing band was detected by
Ponceau S staining and excised. The excised strip was incub-
ated with 10 ml of crude polyclonal anti-CTSBP2 antisera
in 1 ml of blocking solution. After rotation at 4 C overnight,
the strip was subjected to three 15 min washes in TBST.
The bound antibody was eluted in 150 ml of 0.1 M Glycine
pH 2.5 for 1 min. The eluent was removed from the strip,
and 15 ml of 1 M Tris–HCl pH 8.0 was then added to neutra-
lize the mixture. This preparation was diluted into 10 ml
blocking solution and used without any further dilution to
probe immunoblots as indicated.
Ribosome binding assays
Fifty microliter reaction in PBSD contained 6.0 pmol of
XH-CTSBP2 in the presence or absence a 5-fold molar excess
of wild-type or mutant radiolabeled GPX4 SECIS RNA for
10 min at 37 C. Next, a 2.5-fold excess (with respect to
XH-CTSBP2) of salt-washed ribosomes puriﬁed from
McArdle 7777 cells as described below was added and incub-
ated for an additional 5 min at 37 C. SBP2 only reactions were
supplemented with 2 mg/ml bovine serum albumin as carrier:
45 ml of the mixture was layered onto a 200 ml of 20% sucrose
cushion in PBSD and spun at 300000 g for 30 min at 4 Ci na
Sorvall S80-AT2 rotor. The supernatant was removed and the
pellet was re-suspended in 50 ml of 0.5% SDS: 5% of each
(supernatant and pellet) was resolved by 12% SDS–PAGE,
blotted to nitrocellulose and probed with 1:10000 dilution of
crude anti-SBP2 polyclonal antibody.
For the competition studies during in vitro translation,
untagged FLSBP2 was translated in the presence of
35S-Met for 30 min in a 200 ml rabbit reticulocyte reaction
(Promega). Aliquots of25 mlwere prepared and equalvolumes
of either water or in vitro transcribed GPX-4 mRNA was
added and allowed to translate for another 30 min. Sub-
sequently, EDTA was added to the reactions to a ﬁnal con-
centration of 5 mM, and tubes were mixed and brieﬂy
centrifuged: 20 ml of each reaction was layered over a
200 ml 20% sucrose cushion. Samples were spun as described
for the in vitro assay: 5% of supernatants and pellets were run
on a 12% SDS–PAGE gel, which were ﬁxed and dried.
Radiolabeled SBP2 was detected by PhosphorImaging,
and bands were quantiﬁed using ImageQuant software (GE
Healthcare).
Radiolabeling SECIS RNAs
Wild-type and mutant rat GPX4 SECIS element RNAs were
transcribed from Hind III linearized plasmids bearing a 217 nt
insert derived from the GPX4 30 untranslated region (16).
RNA was transcribed with T7 RNA polymerase (Promega)
according to the manufacturer’s protocol except that 1 mlo f
[a-
32P]UTP was added. RNAs were puriﬁed by diluting the
reactions to 50 ml with water and extracting with an equal
volume of 1:1 phenol:chloroform followed by buffer exchange
in a Micro Bio-Spin chromatography column (Bio-Rad). To
isolate radiolabeled SECIS RNA from the supernatant and
pellet fractions, 1 ml of Trizol (Invitrogen) was added, and
RNA was extracted as per the manufacturer’s protocol. RNA
pellets were re-suspended in 20 ml of nuclease-free water,
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Ribosome purification
Ribosomes were puriﬁed from McArdle 7777 cells grown to
80–100% conﬂuence as adapted from a previously described
preparation of yeast 80S salt-washed ribosomes (17). Brieﬂy,
cells from ten 78 cm
2 plates were scraped and collected in 1 ml
ribosome buffer per plate (100 mM KOAc, 20 mM HEPES–
KOH, pH 7.6, 2.5 mM Mg(OAc)2, 2 mM DTT, 1 mg/ml of
heparin and 1· Complete protease inhibitors (Roche). Cells
were lysed by dounce homogenizing with a high clearance
pestle for 10 strokes on ice and extracts were spun at 17000 g
for 15 min (all spins were performed at 4 C in a Sorvall
S80-AT3 rotor). To pellet ribosomes, the supernatant was
spun at 300000 g for 45 min. After rinsing the ribosomal
pellets in 0.5 ml of ribosome buffer, the pellets were resus-
pended in 2.5 ml of high-salt buffer (ribosome buffer plus
500 mM KCl) and stirred for 30–90 min. To clear insoluble
material, samples were spun at 14000 g for 10 min and the
supernatant was transferred to a new tube. This step was
performed several times until no visible pellet could be seen.
Finally, cleared ribosomes were transferred on top of a 0.5 ml
of 1 M sucrose cushion in high-salt buffer and spun at 300000
g for 30 min. Ribosomal pellets were re-suspended in 0.1 ml of
PBSD and stored in aliquots at  80 C.
RESULTS
Gel filtration chromatography of recombinant SBP2
Previous work has suggested that the fully functional
C-terminal half of SBP2 bearing an N-terminal Strep-tag
(ST-CTSBP2) exists in a self-associated complex (8). In
order to deﬁne the aggregate molecular weight of puriﬁed
ST-CTSBP2, we performed Sephadex 200 gel ﬁltration chro-
matography. As shown in Figure 1A, ST-CTSBP2 (which has
a predicted molecularweight of 51 kDa)elutes bothinthe void
fraction (>1300 kDa) as well as into the included fraction
but outside the upper limit of separation range (600 kDa),
suggesting a distribution of high molecular weight complexes.
To assess the contribution of the Strep-tag, if any, to the
aggregate molecular weight, both C-terminal and full-length
SBP2 bearing N-terminal Xpress/His tags (XH-CTSBP2 and
XH-FLSBP2, respectively) were puriﬁed from E.coli extracts.
These proteins, when chromatographed under conditions
identical to those for ST-CTSBP2, eluted as single peaks cor-
responding to 195 and 390 kDa, respectively (Figure 1A). The
expected molecular weights for these proteins are 54 and
97 kDa, respectively, suggesting that self-association may
account for the difference between observed and expected
molecular weight. To examine the stability of the apparent
homomultimeric complexes formed, each of the proteins
described above were subjected to gel ﬁltration chromato-
graphy in the presence of 1 M NaCl to disrupt electrostatic
interactions. As shown in Figure 1A, high-salt conditions dis-
rupted theStrep-tagdependent complexbutnotthe XH-tagged
complexes. In fact, the high ionic strength conditions
seem to have caused conformational changes or aggregation
that yielded higher calculated molecular weights than in
low salt (265 kDa for XH-CTSBP2 and 550 kDa for
XH-FLSBP2). These results allow us to conclude that the
Strep-tag causes SBP2 to aggregate into large salt-sensitive
complexes, consistent with previous indications of complex
formation in glycerol gradient sedimentation experiments (8).
In addition, it appears that XH-tagged SBP2 forms a salt-
stable complex at a discrete size that would predict tetrameric
SBP2.
Since Strep-tagged and XH-tagged SBP2 display markedly
different properties during gel ﬁltration, we tested Sec incorp-
oration activity for each form of the protein. For this deter-
mination, a limiting amount (10 ng) of puriﬁed ST-CTSBP2,
XH-CTSBP2 or XH-FLSBP2 was tested for Sec incorporation
activity as described above. Figure 1B shows that this amount
of SBP2, which is in the linear range of activity response (data
not shown), resulted in over a 100-fold increase in Sec incorp-
oration as measured by luciferase activity. This response is
dependent on both the UGA codon and a wild-type SECIS
element (data not shown). Figure 1C shows these data re-
plotted as a function of SBP2 concentration in order to directly
compare speciﬁc activities. Surprisingly, although all of the
ST-CTSBP2 is found to be aggregated into large molecular
weight complexes (Figure 1A), it is only  2-fold less active
than either XH-CTSBP2 or XH-FLSBP2. These results
also conﬁrm the fact that there is no signiﬁcant difference
between in vitro Sec incorporation activity of full-length
and C-terminal SBP2 (9).
SBP2 homomeric complexes are not observed
in pull-down experiments
We tested the ability of SBP2 to interact with itself by
co-expressing CTSBP2 with an N-terminal GST tag (GST-
CTSBP2) and XH-CTSBP2 in E.coli and determined whether
XH-CTSBP2 would co-purify with GST-CTSBP2 on
glutathione agarose. Fractions obtained from the glutathione
column were analyzed by SDS–PAGE on which GST-
CTSBP2 but not XH-CTSBP2 was detectable after Coomassie
staining (Figure 2A). To verify the lack of XH-CTSBP2 in
GST-CTSBP2 containing fractions, a western blot of the same
gel was probed with afﬁnity-puriﬁed anti-SBP2 antibody.
Figure 2B shows that XH-CTSBP2 was not recovered on
glutathione agarose indicating that SBP2 does not self-
associate even under conditions where co-translational asso-
ciation is possible. The converse puriﬁcation was performed
where XH-CTSBP2 was puriﬁed on a nickel agarose column
from which GST-CTSBP2 was not co-puriﬁed (data not
shown). These results are consistent with traditional pull-
down experiments using a variety of tags and matrices, none
of which showed any evidence of SBP2 self-association (data
not shown).
Gel filtration of untagged CTSBP2
Since the pull-down experiments clearly indicate that SBP2 is
monomeric, we tested the role of the XH tag in altering the
retention times for SBP2 by subjecting untagged SBP2 in
crude E.coli extract to the same procedure. We found that
it elutes near the void volume in low salt but at 190 kDa in
high salt (Figure 3). Since the only conserved feature between
mammalian Sec incorporation and that in E.coli is the ribo-
some, and considering the size of the complex, we assume that
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conditions corresponds to untagged SBP2 interacting with
E.coli ribosomes. Indeed, untagged SBP2 can be recovered
in the ribosomal fraction during ultracentrifugation of E.coli
extracts (data not shown), suggesting that the ribosomal
element interacting with SBP2 is conserved from bacteria
to mammals. The calculated molecular weight in high salt
is very similar to that obtained for XH-CTSBP2 in low salt,
suggesting that the XH tag may contribute to the apparent salt-
dependent increase in size observed in Figure 1A. In addition,
theseresults allow us toconclude that the discrepancy between
predicted and observed molecular weight for SBP2 is intrinsic
to its structure.
SBP2 in cell extracts sediments as a 5 MDa complex
due to ribosome association
In order to study the SBP2 complex in mammalian cells,
we determined the apparent molecular weight for SBP2 in
McArdle 7777 cell extracts stably expressing full-length
Figure 1. Molecular weight determination for SBP2. (A) A sample of 75 mg of C-terminal or full-length SBP2 as indicated was resolved by Sephadex 200 gel
filtration chromatography. Fractions were analyzed by SDS–PAGE followed by Coomassie staining and densitometry. The density peaks were aligned with their
corresponding position on overlaid chromatograms of the proteins used as standards (top). Calculated molecular weights for Strep-tagged CTSBP2 (ST-CTSBP2),
Xpress/His-taggedC-terminalSBP2(aminoacids399–846;XH-CTSBP2)andXpress/His-taggedfull-lengthSBP2(XH-FLSBP2)inthepresence(+salt)orabsence
of1 MNaClare shownonthe right.(B) Samplesof10ngofeach typeofSBP2(as indicated)were addedto a reticulocytelysateassaycontainingluciferasemRNA
withaSeccodonatposition258andawild-typeGPX-4SECISelementinsertedinthe30-untranslatedregion.Theaverageluciferaseactivity(±SD)isshownforeach
version of SBP2. The data for the fourth column are from a reaction lacking any added SBP2. (C) The data in B re-plotted as luminescence units per fmol of SBP2.
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Initial experiments using Sephadex 200 gel ﬁltration chroma-
tography indicated that the native VH-FLSBP2 complex was
in the void fraction and outside the resolving power of that
column (data not shown). To resolve larger complexes, we
fractionated the same extract on a Sephacryl S-500 column.
Figure 4A shows that under low-salt conditions, VH-FLSBP2
elutes with a  5 MDa complex, the expected size for euka-
ryotic ribosomes (18). Under high ionic strength conditions,
SBP2 is shifted to a much smaller size ( 500 kDa; Figure 4B),
closely corresponding to the size of puriﬁed XH-FLSBP2
in high-salt conditions as shown in Figure 1A (550 kDa).
To verify this correlation, we resolved puriﬁed XH-FLSBP2
under low-salt conditions and found that it eluted at  500 kDa
as well (Figure 4D). These conditions are unable to resolve
the difference between FLSBP2 run in high salt versus low
salt as described above (data not shown). In order to
demonstrate that the shift of SBP2 to the higher molecular
weight fractions is due to ribosome binding, we incubated
XH-FLSBP2 with puriﬁed, salt-washed rat ribosomes and
fractionated the mixture by Sephacryl S-500 chromatography.
Figure 4C shows that ribosomes alone are able to shift SBP2
to the same high molecular weight fraction found in crude
cell lysates. These results indicate that SBP2 is quantitatively
associated with the ribosomal fraction and that ribosomes can
account for the entire difference between low- and high-salt
conditions.
Figure 2. (A and B) XH-CTSBP2 fails to co-purify with GST-CTSBP2. Both
XH-CTSBP2andGST-CTSBP2wereco-expressedinE.coliandcrudeextracts
were passed over a glutathione agarose column. Fractions were tested for
GST-CTSBP2 content by SDS–PAGE and Coomassie staining. Each fraction
was also tested for the presence of XH-CTSBP2 by western analysis using
an anti-Xpress tag antibody. Lane 1 shows 20 ng of recombinant XH-tagged
SBP2 purified on Nickel-agarose from the co-expressing strain.
Figure 3. Gel filtration of untagged CTSBP2. Samples of 5 mg of crude E.coli
extracts containing untagged CTSBP2 were resolved by Sephadex 200 gel
filtration chromatography in the presence and absence of 1 M NaCl. Fractions
were analyzed by western analysis using affinity-purified anti-SBP2 antibody.
The position of peak fractions relative to standards is shown by an arrow along
with calculated molecular weight. The elution time for XH-CTSBP2 is shown
for reference.
Figure 4. SBP2 is quantitatively associated with the ribosomal fraction.
(A) A sample of 1.25 mg of cytoplasmic extracts (14000 g supernatants
[S14]) from McArdle 7777 cells stably expressing V5/His-tagged FLSBP2
(VH-FLSBP2)wereresolvedbySephacrylS-500gelfiltrationchromatography
in either low salt (150 mM NaCl) or high salt (1 M NaCl) (B) or as indicated.
Fractions were analyzed by western analysis using an anti-V5 antibody.
(C) Purified XH-FLSBP2 (30 pmol) was chromatographed under the same
conditions in the presence of 2 nmol purified salt-washed rat ribosomes.
(D)Asampleof300pmolofXH-FLSBP2waschromatographedintheabsence
of added ribosomes. The fractions for (C) and (D) were analyzed by western
analysis using an anti-SBP2 antibody. The calculated peak molecular weights
are shown at the bottom.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5177SBP2 cannot simultaneously bind to the ribosome
and the GPX-4 SECIS element
We have previously reported that SBP2 is associated with
ribosomes at the level of 28S rRNA interaction (8). Our ori-
ginal hypothesis that SBP2 was at least a dimer suggested a
model where one subunit interacted with a kink-turn in 28S
rRNA (there are potentially seven kink-turn motifs in mam-
malian 28S rRNA). Since we have shown that SBP2 is most
likely monomeric, we wanted to determine whether SBP2
could simultaneously interact with the ribosome and a
SECIS element. For this experiment, a 5-fold molar excess
of either wild-type or mutant
32P-labeled GPX-4 SECIS ele-
ment was added to an SBP2 ribosome binding assay. We used
a sucrose cushion assay to evaluate ribosome binding where a
2.5-fold molar excess of ribosomes relative to XH-CTSBP2
causes most of the SBP2 to pellet through the cushion.
Figure 5A demonstrates that a 5-fold molar excess of wild-
type GPX-4 SECIS element relative to XH-CTSBP2 is able to
effectively compete SBP2 off of pre-formed SBP2/ribosome
complexes albeit incompletely (compare lanes 6 and 7 with
79% of the SBP2 pelleting to lanes 8 and 9 with 49% pellet-
ing). When a mutant SECIS element lacking the core AUGA
motif required for SBP2 binding is used, no competition is
observed (compare lanes 6 and 7 with 10 and 11 with 75%
pelleting). When a mutant SECIS element lacking the con-
served loop region not required for SBP2 binding is used,
competition is once again evident as it reduced the amount
of pelleted SBP2 to 40%. In order to determine if any of
the SECIS element was found in the ribosomal fraction in
an SBP2-dependent manner, RNA was extracted from both
supernatant and pellet fractions and the RNAs resolved by
denaturing polyacrylamide gel electrophoresis. Figure 5A
(lower panel) clearly shows that the radiolabeled SECIS
RNA is not associated with the pellet fractions therefore
indicating that SBP2 cannot simultaneously associate with
the ribosome and a SECIS element.
Since these experiments do not replicate Sec incorporation,
but simply represent a simple in vitro competition assay,
we chose to test whether similar results would be obtained
during active translation of a full-length selenoprotein mRNA.
To that end, a similar experiment was performed in rabbit
reticulocyte lysate using varying amounts of full-length
GPX-4 mRNA harboring either a wild-type or mutant
SECIS element lacking the conserved AUGA motif. GPX-4
mRNAs were translated in reticulocyte lysate containing pre-
translated FLSBP2. After 30 min, EDTA was added to release
Figure 5. The SECIS element competes for ribosomebinding to SBP2. (A) Reactions containing 6 pmolXH-CTSBP2, 15 pmolpurified salt-washed rat ribosomes
(+ribs)and25pmol
32P-UTP-labeledwild-type(wt)ormutantSECISelement(DAUGA,DAAAAC)asindicatedwerelayeredonto200mlof20%sucrosecushions
followed by ultracentrifugation. Each supernatant (S) or pellet (P) (5%) was analyzed by SDS–PAGE and western analysis using an anti-Xpress tag antibody (top
panel).ThepercentofXH-CTSBP2inthepelletfractionsisindicatedbelowthepanelasdeterminedbydensitometry.RNAwasextractedfromtheremainderofthe
supernatant and pellet fractions and subjected to 5% denaturing PAGE (bottom panel). Lanes 1–3 correspond to the inputSECIS RNAs, lanes 4–7 are derivedfrom
reactions lacking SECIS RNA, lanes 8–13 are derived from reactions containing all components, and lanes 14–19 correspond to reactions lacking SBP2. (B) Wild-
typeormutant(DAUGA)full-lengthGPX-4mRNA(200or1000ngasindicated)wasaddedtoaninvitrotranslationreactioncontainingpre-translated,
35S-labeled
full-lengthSBP2(FLSBP2).After30minofcontinuedtranslation,EDTAwasaddedtoafinalconcentrationof5mMinordertoreleasemRNAfrompolysomes.The
reactions were then layered onto sucrose cushions and analyzed for ribosome binding as described in (A). Radiolabeled SBP2 was detected by PhosphorImager
analysis.
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bind the SECIS element and the ribosome during translation,
all components would be found in the ribosomal pellet, even
in the presence of EDTA, which does not affect SBP2/SECIS
or SBP2/ribosome interactions (8,19). If however, SBP2
shifted to SECIS element binding during translation, then at
the time of EDTA addition, all of the SBP2 actively engaged
in Sec incorporation would be shifted to the supernatant.
Figure 5B shows that full-length GPX4 mRNA is also able
to compete for SBP2 binding under conditions where active
translation and Sec incorporation is occurring, as evidenced
by the production of full-length GPX4 protein in reactions
containing wild-type GPX4 mRNA (data not shown). These
data further demonstratethatSBP2isunable tosimultaneously
bind the ribosome and the SECIS element. The same results
were obtained when the C-terminal fragment of SBP2 was
used instead of full-length protein (data not shown). Thus,
using puriﬁed components in vitro as well as in an in vitro
translation system, these experiments indicate that SBP2 is
likely to shift off of ribosomes and onto the SECIS element
during Sec incorporation.
DISCUSSION
The results presented herein allow us to conclude two import-
ant points regarding Sec incorporation: SBP2 does not self-
associate and SBP2 cannot simultaneously interact with a
SECIS element and the ribosome. Thus, we propose a distinct
model for Sec incorporation based on these and other recent
ﬁndings including a role for non-ribosome bound rpL30 in
SECIS element binding (Figure 6). In order for the model
to ﬁt the idea that SBP2 is ribosome bound but cannot
simultaneously bind the SECIS element, it is necessary to
invoke a scenario where SBP2 interacts with a SECIS element
co-translationally thus allowing eEFSec/Sec-tRNA
[Ser]Sec
access to the ribosomal A-site. A possible role for rpL30,
therefore might be to allow SBP2’s reassociation with the
ribosome by competing for SECIS element binding under
those conditions.
In contradiction to previous hypotheses, SBP2 does not act
as a dimer or other homomultimer. The previous assumptions
were based on the Strep-tagged version of SBP2 which
we demonstrate here forms an artiﬁcially large Strep-tag-
dependent complex. Since SBP2 dimerization was a pre-
requisite of the model where SBP2 could simultaneously
interact with both a SECIS element and the ribosome, we
sought to directly test that hypothesis. By demonstrating
that a SECIS element, as well as a full-length selenoprotein
mRNA, can effectively compete for ribosome binding, it
is clear that the previous model was incorrect and that the
SBP2/SECIS element interaction excludes ribosome binding,
at least in vitro. Further experiments will be required to test
the relative afﬁnities and the sequence speciﬁcity of rRNA
binding to gain insight into the interplay between rRNA and
SECIS element binding.
The fact that a SECIS element excludes ribosome binding
provides further evidence that SBP2 is likely to be interacting
with the ribosome at one of the kink-turn elements within 28S
rRNA. However, this hypothesis is in conﬂict with the fact
that a mutation in a conserved residue within the core L7Ae
Figure 6. A revised model for Sec incorporation. (A) The SECIS element is
recognized by SBP2 when the ribosome pauses at the Sec codon. (B) Instead
of termination, Sec is incorporated as SBP2 binds to the SECIS element and
allowseEFSec/Sec-tRNA
[Ser]SecaccesstotheribosomalA-site.(C)AftertRNA
dissociation, rpL30 binds to the altered SECIS element conformation allowing
SBP2 to re-associate with the ribosome.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5179RNA binding domain in SBP2 (G699R), which results in
eliminating SECIS element binding, retained its ability to
bind ribosomes (8). In addition, the same report demonstrated
that the SBP2 functional domain (amino acids 399–517) is
required for full ribosome binding activity. Taken together,
thissuggeststhatSBP2maypossessmultipleribosomecontact
sites and may remain weakly associated with the ribosome
during Sec incorporation, but not when challenged with a
molar excess of SECIS element or full-length selenoprotein
mRNA as described here.
Our initial observation of the SBP2 ribosome binding activ-
ity indicated that all of the transfected SBP2 was bound to
ribosomes (8). Those experiments were performed using tran-
sient transfection in McArdle 7777 cells where transfection
efﬁciency is generally low ( 20%). Thus, it is possible that
the limited amount of SBP2 per cell allowed unbound SBP2 to
associatewith ribosomes duringextraction.Usinggel ﬁltration
chromatography, we have demonstrated similar results, but
using cells stably transfected with SBP2. These results support
the idea that SBP2 is stably bound to ribosomes suggesting
that SECIS element interactions only occur on actively trans-
lating selenoprotein mRNAs. This result appears to be in con-
ﬂict with a previous report showing that SECIS-containing
mRNAs co-immunoprecipitated with SBP2. However, all of
the mRNA detected in that experiment could have derived
from the actively translating pool—a possibility that was
not investigated at that time (6). It is intriguing to note that
SBP2 apparently shows ribosome binding activity to E.coli
ribosomes (Figure 3). This combined with the fact that SBP2
also binds to yeast ribosomes (an organism lacking Sec; Paul
R. Copeland, unpublished results) suggests that the SBP2
binding site is a universally conserved ribosomal feature, per-
haps not surprising for a binding site targeted by a factor that
regulates processes as generally conserved as translation
elongation and termination.
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